What people fail to understand is that literally months and months of delay have arisen from applications from other biotech companies that needed to be changed after the RA had dismissed the initial submission. NWBO wants to calm the market down by saying that is NOT the case here.
That's exactly what I thought when they told us that there have been no amendments since December 2023. This applies only to submissions. Therefore, it's still premature to conclude that there will be no RFI. Why is there always vagueness in the statement? Why is there always confusion in the statement?
News 
Market Data 
Discover 
